NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
An Evidence Framework for Genetic Testing
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Board on the Health of Select Populations; Committee on the Evidence Base for Genetic Testing.
Advances in genetics and genomics are transforming medical practice, resulting in a dramatic growth of genetic testing in the health care system. The rapid development of new technologies, however, has also brought challenges, including the need for rigorous evaluation of the validity and utility of genetic tests, questions regarding the best ways to incorporate them into medical practice, and how to weigh their cost against potential short- and long-term benefits. As the availability of genetic tests increases so do concerns about the achievement of meaningful improvements in clinical outcomes, costs of testing, and the potential for accentuating medical care inequality.
Given the rapid pace in the development of genetic tests and new testing technologies, An Evidence Framework for Genetic Testing seeks to advance the development of an adequate evidence base for genetic tests to improve patient care and treatment. Additionally, this report recommends a framework for decision-making regarding the use of genetic tests in clinical care.
Contents
Suggested citation:
National Academies of Sciences, Engineering, and Medicine. 2017. An evidence framework for genetic testing. Washington, DC: The National Academies Press. doi: 10.17226/24632.
- NLM CatalogRelated NLM Catalog Entries
- American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.[J Clin Oncol. 2003]American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.American Society of Clinical Oncology. J Clin Oncol. 2003 Jun 15; 21(12):2397-406. Epub 2003 Apr 11.
- Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.[Evid Rep Technol Assess (Summ)...]Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.Hersh WR, Wallace JA, Patterson PK, Shapiro SE, Kraemer DF, Eilers GM, Chan BK, Greenlick MR, Helfand M. Evid Rep Technol Assess (Summ). 2001 Aug; (24 Suppl):1-32.
- Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil.[J Community Genet. 2015]Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil.Ashton-Prolla P, Goldim JR, Vairo FP, da Silveira Matte U, Sequeiros J. J Community Genet. 2015 Jul; 6(3):275-83. Epub 2015 Jun 4.
- Review Genetic testing in primary care.[Annu Rev Genomics Hum Genet. 2...]Review Genetic testing in primary care.Burke W. Annu Rev Genomics Hum Genet. 2004; 5:1-14.
- Review Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin[ 2013]Review Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine OriginMeleth S, Whitehead N, Evans TS, Lux L. 2013 Feb 20
- An Evidence Framework for Genetic TestingAn Evidence Framework for Genetic Testing
- DGCR2 [Canis lupus dingo]DGCR2 [Canis lupus dingo]Gene ID:112676988Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...